Skip to Main Content

Paper Details

Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
Pharmacoepidemiol Drug Saf
7
2022
Author NameAffiliation
Shirley V WangDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Joshua J GagneDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2